[Federal Register Volume 68, Number 231 (Tuesday, December 2, 2003)]
[Notices]
[Pages 67450-67455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-29895]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Youth Violence Prevention Through Community-Level Change

    Announcement Type: New.
    Funding Opportunity Number: 04054.
    Catalog of Federal Domestic Assistance Number: 93.136.

Key Dates

    Letter of Intent Deadline: January 2, 2004.
    Application Deadline: February 17, 2004.

I. Funding Opportunity Description

    Authority: This program is authorized under section 391(a) of the 
Public Health Service Act, [42 U.S.C. section 280b(a), as amended].
    Purpose: The purpose of the program is to announce the availability 
of fiscal year (FY) 2004 funds for a cooperative agreement program for 
the evaluation of community-level interventions to reduce youth 
violence.
    This program addresses the ``Healthy People 2010'' focus area 
Injury and Violence Prevention.
    Measurable outcomes of the program will be in alignment with the 
following performance goal for the National Center for Injury 
Prevention and Control (NCIPC): Conduct a targeted program of research 
to reduce injury-related death and disability.
    Research Objectives: Youth violence has been linked to a variety of 
factors, including individual, family, community, and societal 
characteristics. While much research has been conducted on 
interventions with individuals and families, less often have 
interventions focused on variables at the broader community level.
    There are a number of characteristics of communities that increase 
the probability of violence. Rates of violence are high in areas that 
have large concentrations of poor and unemployed people, crowded 
housing, residential instability, family disruption, illegal drug 
distribution and sales, diminished private economic activity, and 
limited positive opportunities for youths and adults (Reiss & Roth, 
1993; Sampson & Lauritsen, 1994). Rates of violence are also high in 
neighborhoods where there is low community participation, 
disorganization, and a lack of cohesion. People living in these types 
of communities tend to be socially isolated and exhibit lower levels of 
attachment to the community--factors that also

[[Page 67451]]

limit their ability to supervise and control adolescent peer groups, 
especially gangs (Sampson & Lauritsen, 1994).
    Research funded under this announcement is expected to address this 
important gap in the prevention literature (i.e., the implementation 
and evaluation of interventions that are designed to modify the above 
types of community characteristics). The ultimate aim of such an 
approach is to assess whether interventions designed to change 
community structures and social processes can reduce rates of youth 
violence in communities.
    At a minimum, competitive applicants will provide theoretical 
rationale and empirical evidence in support of the specific 
intervention proposed, and will conduct a rigorous evaluation of the 
intervention.

Activities

    Awardee activities for this program are as follows:
    [sbull] Develop and finalize the research design and methodology, 
data collection measures, and analyses, and disseminate study results 
through publications and presentations.
    [sbull] Develop a research protocol for Institutional Review Board 
(IRB) review by all cooperating institutions participating in the 
research project.
    [sbull] Obtain approval of the study protocol by the recipient's 
local IRB.
    [sbull] Collect data on the costs associated with implementing and 
evaluating the intervention.
    [sbull] Conduct one reverse site visit to meet with CDC staff in 
Atlanta on an annual basis.
    [sbull] Complete all required reports as specified under 
``Reporting Requirements''.
    [sbull] Provide a protocol/manual documenting the intervention and 
the manner in which it was implemented, including any information on 
activities occurring prior to the start of the intervention, such as 
stakeholder meetings, collaboration building, or focus groups.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
    [sbull] Provide scientific and programmatic consultation. CDC will 
collaborate with project staff on decision-analyses, programmatic 
issues, and dissemination of the study results in publications and 
presentations.
    [sbull] Assist in the development of a research protocol for IRB 
review by all cooperating institutions participating in the research 
project. The CDC IRB will review and approve the protocol initially and 
on at least an annual basis until the research project is finished.
    [sbull] CDC staff will monitor and review scientific and 
operational accomplishments of the project through conference calls, 
site visits, and review of technical reports.

II. Award Information

    Type of Award: Cooperative Agreement.
    CDC involvement in this program is listed in the Activities Section 
above.
    Fiscal Year Funds: 2004.
    Approximate Total Funding: 1,000,000.
    Approximate Number of Awards: Two.
    Approximate Average Award: 500,000.
    Floor of Award Range: $250,000.
    Ceiling of Award Range: $500,000.
    Anticipated Award Date: September 1, 2004.
    Budget Period Length: 12 months.
    Project Period Length: Four years.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government.

III. Eligibility Information

    III.1. Eligible applicants: Applications may be submitted by public 
and private nonprofit and for profit organizations and by governments 
and their agencies, such as:
    [sbull] Public nonprofit organizations.
    [sbull] Private nonprofit organizations.
    [sbull] For profit organizations.
    [sbull] Small, minority, women-owned businesses.
    [sbull] Universities.
    [sbull] Colleges.
    [sbull] Research institutions.
    [sbull] Hospitals.
    [sbull] Community-based organizations.
    [sbull] Faith-based organizations.
    [sbull] Federally recognized Indian tribal governments.
    [sbull] Indian tribes.
    [sbull] Indian tribal organizations.
    [sbull] State and local governments or their Bona Fide Agents (this 
includes the District of Columbia, the Commonwealth of Puerto Rico, the 
Virgin Islands, the Commonwealth of the Northern Marianna Islands, 
American Samoa, Guam, the Federated States of Micronesia, the Republic 
of the Marshall Islands, and the Republic of Palau).
    [sbull] Political subdivisions of States (in consultation with 
States).
    A Bona Fide Agent is an agency/organization identified by the state 
as eligible to submit an application under the state eligibility in 
lieu of a state application. If you are applying as a bona fide agent 
of a state or local government, you must provide a letter from the 
state or local government as documentation of your status. Place this 
documentation behind the first page of your application form.
    III.2. Cost Sharing or Matching: Matching funds are not required 
for this program.
    III.3. Other Eligibility Requirements: If you request a funding 
amount greater than the ceiling of the award range, your application 
will be considered non-responsive, and will not be entered into the 
review process. You will be notified that your application did not meet 
the submission requirements.
    If your application is incomplete or non-responsive to the 
requirements listed below, it will not be entered into the review 
process. You will be notified that your application did not meet 
submission requirements. The following are applicant requirements:
    [sbull] A principal investigator who has documented prior training 
and experience in conducting efficacy and effectiveness trials.
    [sbull] A principal investigator who has conducted research, 
published the findings in peer-reviewed journals, and has specific 
authority and responsibility to carry out the proposed project.
    [sbull] Demonstrated experience on the applicant's project team in 
conducting, evaluating, and publishing violence prevention research in 
peer-reviewed journals.
    [sbull] Effective and well-defined working relationships within the 
performing organization and with outside entities, which will ensure 
implementation of the proposed activities.
    [sbull] The overall match between the applicant's proposed research 
objectives and the program priorities as described under the heading, 
``Funding Priority''.
    [sbull] The requested funding amount is within the award range of 
$250,000-$500,000.
    [sbull] Principal investigators (PI's) are encouraged to submit 
only one proposal in response to this program announcement. With few 
exceptions (e.g., research issues needing immediate public health 
attention), only one application per PI will be funded under this 
announcement.

[[Page 67452]]

4. Individuals Eligible To Become Principal Investigators

    Any individual with the skills, knowledge, and resources necessary 
to carry out the proposed research is invited to work with their 
institution to develop an application for support. Individuals from 
underrepresented racial and ethnic groups as well as individuals with 
disabilities are always encouraged to apply for CDC programs.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant, or loan.

IV. Application and Submission Information

    IV.1. Address to Request Application Package: To apply for this 
funding opportunity, use application form PHS 398 (OMB number 0925-0001 
rev. 5/2001). Forms and instructions are available in an interactive 
format on the CDC Web site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm.
    Forms and instructions are also available in an interactive format 
on the National Institutes of Health (NIH) Web site at the following 
Internet address: http://grants.nih.gov/grants/funding/phs398/phs398.html.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Application Submission

    Letter of Intent (LOI): CDC requests that you send a LOI if you 
intend to apply for this program. Although the LOI is not required, not 
binding, and does not enter into the review of your subsequent 
application, your LOI will be used to gauge the level of interest in 
this program, and to allow CDC to plan the application review. Your LOI 
must be written in the following format:
    [sbull] Maximum number of pages: Two.
    [sbull] Font size: 12-point unreduced.
    [sbull] Paper size: 8.5 by 11 inches.
    [sbull] Page margin size: One inch.
    [sbull] Single spaced.
    [sbull] Printed only on one side of page.
    [sbull] Written in English, avoid jargon.
    Your LOI must contain the following information:
    [sbull] Descriptive title of the proposed research.
    [sbull] Name, address, E-mail address, and telephone number of the 
Principal Investigator.
    [sbull] Names of other key personnel.
    [sbull] Participating institutions.
    [sbull] Number and title of this Program Announcement (PA).
    Application: Follow the PHS 398 application instructions for 
content and formatting of your application (See Attachment 1 of this 
announcement for guidance on how to complete Form 398 for this Program 
Announcement). The Program Announcement Title and number must appear in 
the application. For further assistance with the PHS 398 application 
form, contact GrantsInfo, Telephone (301) 435-0714, E-mail: 
[email protected].
    Your research plan should address activities to be conducted over 
the entire project period.
    You must include a research plan with your application. The 
research plan should be no more than 25 pages (8.5'' x 11'' in size), 
single-spaced, printed on one side only, with one-inch margins on all 
sides, and unreduced 12-point font. Your application will be evaluated 
on the criteria listed under Section V. ``Application Review 
Information'', so it is important to follow them, as well as the 
Research Objectives and the Administrative and National Policy 
Requirements (ARs), in laying out your research plan. Your research 
plan should address activities to be conducted over the entire project 
period. The research plan should consist of the following information:
    1. Abstract: It is especially important to include an abstract that 
reflects the project's focus, because the abstract will be used to help 
determine the responsiveness of the application.
    2. Program Goals and Objectives: Describe the goals and objectives 
the proposal is designed to achieve in the short and long term. 
Specific research questions and hypotheses should also be included.
    3. Program Participants: Describe the demographic and geographic 
characteristics of the community and/or neighborhood targeted by the 
intervention. This section should include incidence, prevalence, 
morbidity, and/or mortality rates associated with youth violence within 
that community. In addition, the proposal should provide evidence that 
the recipient (or collaborating partner) has access to the target 
community, and that the participation by the target community in the 
intervention will be adequate.
    4. Intervention: Describe the proposed strategies or components of 
the intervention and the plan for implementing the intervention. 
Proposals should explicate the theoretical and empirical justification 
for the potential effectiveness of the intervention for reducing youth 
violence in the target community. This should include discussion of the 
modifiable risk and protective factors that will be influenced by the 
intervention of interest. The proposal should describe the location or 
setting in which the intervention component(s) will occur, and describe 
the relevance of this setting to the strategy and desired outcomes.
    5. Evaluation Design: Describe the proposed design, methods and 
analysis plan for assessing the effectiveness of the intervention. The 
specific type of evaluation method chosen should reflect the nature of 
the intervention, feasibility, and ethical considerations. Potential 
threats to the validity of the study should be described along with how 
such threats will be recognized and addressed. The status of all 
necessary measurement instruments should be described. If any materials 
are not extant, the methods and time frame for measure development, 
pilot testing, and validation should be given. For data collected from 
archival records (e.g., hospital records, police records, etc.) the 
proposal should discuss issues of accessibility, reliability, and 
validity of those data.
    6. Project Management: Provide evidence of the expertise, capacity, 
and community support necessary to successfully implement the 
intervention to reduce community indicators of youth violence. 
Proposals should also provide evidence of expertise and capacity to 
evaluate the impact of the intervention. Each existing or proposed 
position for the project should be described by job title, function, 
general duties, level of effort and allocation of time. Management 
operation principles, structure, and organization should also be noted.
    7. Collaborative Efforts: List and describe the current and 
proposed collaborations with government, health, or youth agencies, 
community- or faith-based organizations, minority organizations, and 
other researchers. Include letters of support and memoranda of 
understanding that specify the nature of past, present, and proposed 
collaborations, and the products/services/activities that will be 
provided by and to the applicant.
    8. Data sharing and release: Describe plans for the sharing and 
release of data (See AR-25 for additional information).
    9. Project Budget: Provide a detailed budget for each activity 
undertaken, with accompanying justification of all

[[Page 67453]]

operating expenses that is consistent with the stated objectives and 
planned activities of the project.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. Your DUNS number must be entered 
in item 11 of the face page of the PHS 398 application form. The DUNS 
number is a nine-digit identification number, which uniquely identifies 
business entities. Obtaining a DUNS number is easy and there is no 
charge. To obtain a DUNS number, access http://www.dunandbradstreet.com 
or call 1-866-705-5711.
    For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.

IV.3. Submission Dates and Times

    LOI Deadline Date: January 2, 2004.
    Application Deadline Date: February 17, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery service, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If CDC receives your application after closing due to: (1) 
carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.
    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that your application did not meet the 
submission requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for applications to be 
processed and logged.
    4. Intergovernmental Review of Applications: Executive Order 12372 
does not apply to this program.
    5. Funding Restrictions: Restrictions, which must be taken into 
account while writing your budget, are as follows:

Funding Priority

    Priority will be given to the evaluation of primary prevention 
interventions and programs that focus on the social and economic 
environment (relationships among people and settings) and/or the 
physical environment (tangible surroundings or resources available to 
youth or the community at large), over those that focus on criminal 
justice responses (e.g., community policing, arrest strategies). These 
include:
    [sbull] Strategies to increase social integration and cohesion by 
increasing community participation as well as formal and informal 
social support.
    [sbull] Strategies to improve the physical and social 
characteristics of neighborhoods through environmental design changes 
(e.g., Crime Prevention Through Environmental Design).
    [sbull] Strategies to improve financial, housing, and/or employment 
issues in impoverished areas.
    [sbull] Efforts to deconcentrate areas with high rates of poverty 
and violence.
    [sbull] Strategies to increase formal and/or informal supervision 
of youth (such as providing structured or unstructured activities to 
youth during non-school hours, or encouraging adults to monitor youths' 
activities in their neighborhood).
    [sbull] Strategies to reduce community density and availability of 
alcohol and drugs.
    [sbull] Strategies to modify social norms about violence or other 
related issues and values.

Funding Preferences

    Funding preference will be given to proposals that:
    [sbull] Propose more stringent and rigorous evaluation designs, 
including: experimental and quasi-experimental designs with appropriate 
baseline/pre-intervention data, post-intervention data, and at least 
one follow-up data collection point; data from at least one comparison 
or control community; and data collected from multiple sources.
    [sbull] Measure outcomes and impacts at the neighborhood or 
community level and focus on risk and protective factors specific to 
that level of intervention. Examples could include: police records of 
neighborhood or community arrests for violent crimes, violent school 
incidents (aggregated to the school or system level), hospital or 
Emergency Room data aggregated by neighborhood or community, or intake 
rates for juvenile detention facilities.
    [sbull] Propose a conceptual model or theory of change for how the 
intervention will produce the intended reductions in youth violence, 
and measure proposed mediators and moderators of program outcomes.
    [sbull] Describe plans for ensuring that the intervention is 
implemented as it was designed (i.e., intervention fidelity) and that 
the target community received or had access to the intervention (i.e., 
program exposure).
    [sbull] Propose data analytic plans that are appropriate to the 
intervention, research design and hypotheses, data collection measures, 
and project period, and that anticipate and evaluate the effect of 
threats to the internal and external validity of the specified research 
design.
    [sbull] Target traditionally underserved communities.
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement.
    If your indirect cost rate is a provisional rate, the agreement 
must be less than 12 months of age.

6. Other Submission Requirements

    LOI Submission Address: Submit your LOI by express mail, delivery 
service, fax, or e-mail to:Robin Forbes, CDC, NCIPC, 4770 Buford Hwy, 
NE, Mailstop K-62, Atlanta, GA 30341,Telephone: 770-488-4037,Fax: 770-
488-1662,E-mail: [email protected].
    Application Submission Address: Submit the original and five copies 
of your application by mail or express delivery service to:Technical 
Information Management--PA 04054, CDC Procurement and Grants 
Office,2920 Brandywine Road,Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

    You are required to provide measures of effectiveness that will 
demonstrate the accomplishment of the various identified objectives of 
the cooperative agreement. Measures of effectiveness must relate to the 
performance goal stated in the ``Purpose'' section of this 
announcement. Measures must be objective and quantitative, and must 
measure the intended outcome. These measures of effectiveness must be 
submitted with the application and will be an element of evaluation.
    The goals of CDC-supported research are to advance the 
understanding of biological systems, improve the control

[[Page 67454]]

and prevention of disease, and enhance health. In the written comments, 
reviewers will be asked to evaluate the application in order to judge 
the likelihood that the proposed research will have a substantial 
impact on the pursuit of these goals.
    The scientific review group will address and consider each of the 
following criteria in assigning the application's overall score, 
weighting them as appropriate for each application. The application 
does not need to be strong in all categories to be judged likely to 
have major scientific impact and thus deserve a high priority score. 
For example, an investigator may propose to carry out important work 
that by its nature is not innovative, but is essential to move a field 
forward.
    The criteria are as follows:
    Significance: Does this study address an important problem? If the 
aims of the application are achieved, how will scientific knowledge be 
advanced? What will be the effect of these studies on the concepts or 
methods that drive this field?
    Approach: Are the conceptual framework, design, methods, and 
analyses adequately developed, scientifically rigorous, well-
integrated, and appropriate to the aims of the project? Does the 
applicant acknowledge potential problem areas and consider alternative 
tactics?
    Innovation: Does the project employ novel concepts, approaches or 
methods? Are the aims original and innovative? Does the project 
challenge existing paradigms or develop new methodologies or 
technologies?
    Investigator: Is the investigator appropriately trained and well 
suited to carry out this work? Is the work proposed appropriate to the 
experience level of the principal investigator and other researchers 
(if any)?
    Environment: Does the scientific environment in which the work will 
be done contribute to the probability of success? Does the proposed 
research take advantage of unique features of the scientific 
environment or employ useful collaborative arrangements? Is there 
evidence of institutional support?
    Additional Review Criteria: In addition to the above criteria, the 
following items will be considered in the determination of scientific 
merit and priority score: Intervention: Is the potential effectiveness 
of the proposed intervention within the target community theoretically 
justified and supported with epidemiologic, methodological, and 
behavioral research? How feasible is the implementation of the 
intervention as proposed? Can the intervention reasonably be predicted 
to produce the expected reductions in youth violence? Is the setting of 
implementation appropriate?
    Protection of Human Subjects from Research Risks: Does the 
application adequately address the requirements of Title 45 CFR part 46 
for the protection of human subjects? This will not be scored; however, 
an application can be disapproved if the research risks are 
sufficiently serious and protection against risks is so inadequate as 
to make the entire application unacceptable.
    Inclusion of Women and Minorities in Research: Does the application 
adequately address the CDC Policy requirements regarding the inclusion 
of woman, ethnic, and racial groups in the proposed research? This 
includes: (1) The proposed plan for the inclusion of both sexes and 
racial and ethnic minority populations for appropriate representation; 
(2) The proposed justification when representation is limited or 
absent; (3) A statement as to whether the design of the study is 
adequate to measure differences when warranted; and (4) A statement as 
to whether the plans for recruitment and outreach for study 
participants include the process of establishing partnerships with 
community(ies) and recognition of mutual benefits.
    INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN 
SUBJECTS: The NIH maintains a policy that children (i.e., individuals 
under the age of 21) must be included in all human subjects research, 
conducted or supported by the NIH, unless there are scientific and 
ethical reasons not to include them. This policy applies to all initial 
(Type 1) applications submitted for receipt dates after October 1, 
1998.
    All investigators proposing research involving human subjects 
should read the ``NIH Policy and Guidelines'' on the inclusion of 
children as participants in research involving human subjects that is 
available at: http://grants.nih.gov/grants/funding/children/children.htm.
    Budget: The reasonableness of the proposed budget and the requested 
period of support in relation to the proposed research.
    V.2. Review and Selection Process: Applications will be reviewed 
for completeness by the Procurement and Grants Office (PGO) staff for 
completeness and for responsiveness by the National Center for Injury 
Prevention and Control. Incomplete applications and applications that 
are non-responsive will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    Applications that are complete and responsive to the PA will be 
subjected to a preliminary evaluation (streamline review) by a peer 
review committee, the Initial Review Group (IRG) convened by NCIPC, to 
determine if the application is of sufficient technical and scientific 
merit to warrant further review by the IRG. CDC will withdraw from 
further consideration applications judged to be noncompetitive and 
promptly notify the principal investigator or program director and the 
official signing for the applicant organization. Those applications 
judged to be competitive will be further evaluated by a dual review 
process.
    1. The primary review will be a peer review conducted by the IRG. 
All applications will be reviewed for scientific merit in accordance 
with the review criteria listed above. Applications will be assigned a 
priority score based on the National Institutes of Health (NIH) scoring 
system of 100-500 points.
    2. The secondary review will be conducted by the Science and 
Program Review Subcommittee (SPRS) of NCIPC's Advisory Committee for 
Injury Prevention and Control (ACIPC). The ACIPC Federal agency experts 
will be invited to attend the secondary review, and will receive 
modified briefing books (i.e., abstracts, strengths and weaknesses from 
summary statements, and project officer's briefing materials). ACIPC 
Federal agency experts will be encouraged to participate in 
deliberations when applications address overlapping areas of research 
interest, so that unwarranted duplication in federally-funded research 
can be avoided and special subject area expertise can be shared. The 
NCIPC Division Associate Directors for Science (ADS) or their designees 
will attend the secondary review in a similar capacity as the ACIPC 
Federal agency experts to assure that research priorities of the 
announcement are understood and to provide background regarding current 
research activities. Only SPRS members will vote on funding 
recommendations, and their recommendations will be carried to the 
entire ACIPC for voting by the ACIPC members in closed session. If any 
further review is needed by the ACIPC, regarding the recommendations of 
the SPRS, the factors considered will be the same as those considered 
by the SPRS.
    The secondary review committee's responsibility is to develop 
funding recommendations for the NCIPC Director based on the results of 
the primary review, the relevance and balance of proposed research 
relative to the NCIPC programs and priorities, and

[[Page 67455]]

to assure that unwarranted duplication of federally-funded research 
does not occur. The secondary review committee has the latitude to 
recommend to the NCIPC Director, to reach over better-ranked proposals 
in order to assure maximal impact and balance of proposed research. The 
factors to be considered will include:
    a. The results of the primary review including the application's 
priority score as the primary factor in the selection process.
    b. The relevance and balance of proposed research relative to the 
NCIPC programs and priorities.
    c. The significance of the proposed activities in relation to the 
priorities and objectives stated in ``Healthy People 2010,'' the 
Institute of Medicine report, ``Reducing the Burden of Injury,'' and 
the ``CDC Injury Research Agenda.''
    All awards will be determined by the Director of the NCIPC based on 
priority scores assigned to applications by the IRG, recommendations by 
the secondary review committee, ACIPC, consultation with NCIPC senior 
staff, and the availability of funds.
    Award Criteria: Criteria that will be used to make award decisions 
include:
    [sbull] Scientific merit (as determined by peer review)
    [sbull] Availability of funds
    [sbull] Programmatic priorities

VI. Award Administration Information

    VI.1. Award Notices: Successful applicants will receive a Notice of 
Grant Award (NGA) from the CDC Procurement and Grants Office. The NGA 
shall be the only binding, authorizing document between the recipient 
and CDC. The NGA will be signed by an authorized Grants Management 
Officer, and mailed to the recipient fiscal officer identified in the 
application.
    2. Administrative and National Policy Requirements: 45 CFR part 74 
and part 92.
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:
    [sbull] AR-1 Human Subjects Requirements
    [sbull] AR-2 Requirements for Inclusion of Women and Racial and 
Ethnic Minorities in Research
    [sbull] AR-8 Public Health System Reporting Requirements
    [sbull] AR-9 Paperwork Reduction Act Requirements
    [sbull] AR-10 Smoke-Free Workplace Requirements
    [sbull] AR-11 Healthy People 2010
    [sbull] AR-12 Lobbying Restrictions
    [sbull] AR-13 Prohibition on Use of CDC Funds for Certain Gun 
Control Activities
    [sbull] AR-14 Accounting System Requirements
    [sbull] AR-15 Proof of Non-Profit Status
    [sbull] AR-16 Security Clearance Requirement
    [sbull] AR-21 Small, Minority, and Women-Owned Business
    [sbull] AR-22 Research Integrity
    [sbull] AR-23 States and Faith-Based Organizations
    [sbull] AR-24 Health Insurance Portability and Accountability Act 
Requirements
    [sbull] AR-25 Release and Sharing of Data

    Starting with the December 1, 2003 receipt date, all NCIPC 
funded investigators seeking more than $250,000 in total costs in a 
single year are expected to include a plan describing how the final 
research data will be shared/released or explain why data sharing is 
not possible. Details on data sharing/release, including the 
timeliness and name of the project data steward, should be included 
in a brief paragraph immediately following the Research Plan Section 
of the PHS 398 form. References to data sharing/release may also be 
appropriate in other sections of the application (e.g. background 
and significance, human subjects requirements, etc.). The content of 
the data sharing/release plan will vary, depending on the data being 
collected and how the investigator is planning to share the data. 
The data sharing/release plan will not count towards the application 
page limit and will not factor into the determination scientific 
merit or priority scores. Investigators should seek guidance from 
their institutions, on issues related to institutional policies, 
local IRB rules, as well as local, state and Federal laws and 
regulations, including the Privacy Rule.
    Further detail on the requirements for addressing data sharing 
in applications for NCIPC funding may be obtained by contacting 
NCIPC program staff or visiting the NCIPC Internet Web site at: 
http://www.cdc.gov/ncipc/osp/sharing_policy.htm.

    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.
    VI.3. Reporting: You must provide CDC with an original, plus two 
copies of the following reports:
    1. Interim progress report, (PHS 2590, OMB Number 0925-0001, rev. 
5/2001) no less than 90 days before the end of the budget period. The 
progress report will serve as your non-competing continuation 
application, and must contain the following elements:
    a. Current Budget Period Activities Objectives.
    b. Current Budget Period Financial Progress.
    c. New Budget Period Program Proposed Activity Objectives.
    d. Detailed Line-Item Budget and Justification.
    e. Additional Requested Information.
    f. Measures of Effectiveness.
    2. Financial status report, no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management Specialist 
listed in the ``Agency Contacts'' section of this announcement.

VII. Agency Contacts

    For general questions about this announcement, contact:Technical 
Information Management Section, CDC Procurement and Grants Office,2920 
Brandywine Road,Atlanta, GA 30341,Telephone: 770-488-2700.
    For scientific/research program technical assistance, 
contact:Jennifer Wyatt, Behavioral Scientist, Centers for Disease 
Control and Prevention,4770 Buford Highway, NE, MS K-60,Atlanta, 
Georgia 30341,Telephone: 770-488-4058,E-mail: [email protected].
    For questions about peer review, contact: Gwendolyn Cattledge, 
Scientific Review Administrator, Centers for Disease Control and 
Prevention, 4770 Buford Highway, NE, MS K-02, Atlanta, Georgia 30341, 
Telephone: 770-488-1430, E-mail: [email protected].
    For budget assistance, contact:
    Nancy Pillar, Grants Management Specialist, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-
488-2721, E-mail: [email protected].

    Dated: November 25, 2003.
Edward Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-29895 Filed 12-1-03; 8:45 am]
BILLING CODE 4163-18-P